Relaxin and related peptides in male reproduction

Advances in Experimental Medicine and Biology

Volumn 612, Issue , 2007, Pages 49-64

  Agoulnik, Alexander I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LGR7 RECEPTOR; LGR8; RELAXIN; RELAXIN 3; RELAXIN 5; UNCLASSIFIED DRUG; INSL5 PROTEIN, MOUSE; INSL6 PROTEIN, HUMAN; INSL6 PROTEIN, MOUSE; INSULIN; LEYDIG INSULIN LIKE PROTEIN; LEYDIG INSULIN-LIKE PROTEIN; PEPTIDE HORMONE; PROTEIN; RXFP2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; CRYPTORCHISM; GENE DELETION; GENE MUTATION; HUMAN; MALE GENITAL SYSTEM; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SPERM; TESTIS; TESTIS DESCENT; VAS DEFERENS; ANIMAL; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LEYDIG CELL; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; REPRODUCTION;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEYDIG CELLS; MALE; MICE; PEPTIDE HORMONES; PREGNANCY; PROSTATE; PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RELAXIN; REPRODUCTION;

EID: 38749091351     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74672-2_5     Document Type: Review

References (116)

1. Weiss G. Relaxin in the male. Biol Reprod 1989; 40(2):197-200.
2. Kohsaka T, Takahara H, Sasada H et al. Evidence for immunoreactive relaxin in boar seminal vesicles using combined light and electron microscope immunocytochemistry. J Reprod Fertil 1992; 95(2):397-408.
3. Essig M, Schoenfeld C, D'Eletto RT et al. Relaxin in human seminal plasma. Ann N Y Acad Sci 1982; 380:224-230.
4. Weiss G, Goldsmith LT, Schoenfeld C et al. Partial purification of relaxin from human seminal plasma. Am J Obstet Gynecol 1986; 154(4):749-755.
5. Juang HH, Musah Al, Schwabe C et al. Relaxin in peripheral plasma of boars during development, copulation, after administration of hCG and after castration. J Reprod Fertil 1996; 107(1):1-6.
6. Sokol RZ, Wang XS, Lechago J et al. Immunohistochemical localization of relaxin in human prostate. J Histochem Cytochem 1989; 37(8):1253-1255.
7. Yki-Jarvinen H, Wahlstrom T, Seppala M. Immunohistochemical demonstration of relaxin in the genital tract of men. J Reprod Fertil 1983; 69(2):693-695.
8. Hansell DJ, Bryant-Greenwood GD, Greenwood FC. Expression of the human relaxin H1 gene in the decidua, trophoblast and prostate. Journal of Clinical Endocrinology and Metabolism 1991; 72(4):899-904.
9. Bogic LV, Mandel M, Bryant-Greenwood GD. Relaxin gene expression in human reproductive tissues by in situ hybridization. Journal of Clinical Endocrinology and Metabolism 1995; 80(1):130-137.
10. Gunnersen JM, Fu P, Roche PJ et al. Expression of human relaxin genes: characterization of a novel alternatively-spliced human relaxin mRNA species. Mol Cell Endocrinol 1996; 118(1-2):85-94.
11. Gunnersen JM, Roche PJ, Tregear GW et al. Characterization of human relaxin gene regulation in the relaxin-expressing human prostate adenocarcinoma cell line LNCaP.FGC. Journal of Molecular Endocrinology 1995; 15(2):153-166.
12. Garibay-Tupas JL, Bao S, Kim MT et al. Isolation and analysis of the 3′-untranslated regions of the human relaxin H1 and H2 genes. Journal of Molecular Endocrinology 2000; 24(2):241-252.
13. Winslow JW, Shih A, Bourell JH et al. Human seminal relaxin is a product of the same gene as human luteal relaxin. Endocrinology 1992; 130(5):2660-2668.
14. Hudson P, John M, Crawford R et al. Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones. EMBO Journal 1984; 3(10):2333-2339.
15. Tashima LS, Yamamoto SY, Yasuda M et al. Decidual relaxins: gene and protein up-regulation in preterm premature rupture of the membranes by complementary DNA arrays and quantitative immunocytochemistry. Am J Obstet Gynecol 2002; 187(3):785-797.
16. Anderson MB, Collado-Torres M, Vaupel MR. Absence of relaxin immunostaining in the male reproductive tracts of the rat and mouse. J Histochem Cytochem 1986; 34(7):945-948.
17. Gunnersen JM, Crawford RJ, Tregear GW. Expression of the relaxin gene in rat tissues. Mol Cell Endocrinol 1995; 110(1-2):55-64.
18. Samuel CS, Tian H, Zhao L et al. Relaxin is a key mediator of prostate growth and male reproductive tract development. Lab Invest 2003; 83(7):1055-1067.
19. Thompson VC, Morris TG, Cochrane DR et al. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens. Prostate 2006; 66(16):1698-1709.
20. Garibay-Tupas JL, Okazaki KJ, Tashima LS et al. Regulation of the human relaxin genes H1 and H2 by steroid hormones. Mol Cell Endocrinol 2004; 219(1-2):115-125.
21. Dubois MP, Dacheux JL. Relaxin, a male hormone? Immuncytological localization of a related antigen in the boar testis. Cell Tissue Res 1978; 187(2):201-214.
22. Arakaki RF, Kleinfeld RG, Bryant-Greenwood GD. Immunofluorescence studies using antisera to crude and to purified porcine relaxin. Biol Reprod 1980; 23(1):153-159.
23. Bryant-Greenwood GD, Niall HD, Greenwood FC. Relaxin: proceedings of a Workshop on the Chemistry and Biology of Relaxin held at the East-West Center, the University of Hawaii, Honolulu, Hawaii, 1980. New York: Elsevier/North- Holland, 1981.
24. Parry LJ, Rust W, Ivell R. Marsupial relaxin: complementary deoxyribonucleic acid sequence and gene expression in the female and male tammar wallaby, Macropus eugenii. Biol Reprod 1997; 57(1):119-127.
25. de Rienzo G, Aniello F, Branno M et al. Isolation and characterization of a novel member of the relaxin/ insulin family from the testis of the frog Rana esculenta. Endocrinology 2001; 142(7):3231-3238.
26. Hsu SY, Kudo M, Chen T et al. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol 2000; 14(8):1257-1271.
27. Muda M, He C, Martini PG et al. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity. Mol Hum Reprod 2005; 11(8):591-600.
28. Scott DJ, Layfield S, Yan Y et al. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique LDLa modules. J Biol Chem 2006.
29. Scott DJ, Tregear GW, Bathgate RA. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro. Ann N Y Acad Sci 2005; 1041:22-26.
30. Min G, Sherwood OD. Localization of specific relaxin-binding cells in the ovary and testis of pigs. Biol Reprod 1998; 59(2):401-408.
31. Silvertown JD, Ng J, Sato T et al. H2 relaxin overexpression increases in vivo prostate xenograft: tumor growth and angiogenesis. Int J Cancer 2006; 118(1):62-73.
32. Vinall RL, Tepper CG, Shi XB et al. The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7. Oncogene 2006; 25(14):2082-2093.
33. Zhao L, Roche PJ, Gunnersen JM et al. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 1999; 140(1):445-453.
34. Kamat AA, Feng S, Bogatcheva NV et al. Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology 2004; 145(10):4712-4720.
35. Krajnc-Franken MA, van Disseldorp AJ, Koenders JE et al. Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 2004; 24(2):687-696.
36. Feng S, Bogatcheva NV, Kamat AA et al. Endocrine effects of relaxin overexpression in mice. Endocrinology 2006; 147(1):407-414.
37. Carrell DT, Peterson CM, Urry RL. The binding of recombinant human relaxin to human spermatozoa. Endocr Res 1995; 21(3):697-707.
38. Brenner SH, Lesing JB, Schoenfeld C et al. Human semen relaxin and its correlation with the parameters of semen analysis. Fertil Steril 1987; 47(4):714-716.
39. Schieferstein G, Voelter W, Seeger H et al. Immunoreactive relaxin in seminal plasma of man. Int J Fertil 1989; 34(3):215-218.
40. Sasaki Y, Kohsaka T, Kawarasaki T et al. Immunoreactive relaxin in seminal plasma of fertile boars and its correlation with sperm motility characteristics determined by computer-assisted digital image analysis. Int J Androl 2001; 24(1):24-30.
41. Kohsaka T, Hamano K, Sasada H et al. Seminal immunoreactive relaxin in domestic animals and its relationship to sperm motility as a possible index for predicting the fertilizing ability of sires. Int J Androl 2003; 26(2):115-120.
42. Neuwinger J, Jockenhovel F, Nieschlag E. The influence of relaxin on motility of human sperm in vitro. Andrologia 1990; 22(4):335-339.
43. Sarosi P, Schoenfeld C, Berman J et al. Effect of anti-relaxin antiserum on sperm motility in vitro. Endocrinology 1983; 112(5):1860-1861.
44. Fuchs U. The effect of relaxin and ubiquitin on sperm motility. Zentralbl Gynakol 1993; 115(3):117-120.
45. Jockenhovel F, Altensell A, Nieschlag E. Active immunization with relaxin does not influence objectively determined sperm motility characteristics in rabbits. Andrologia 1990; 22(2):171-178.
46. Essig M, Schoenfeld C, Amelar RD et al. Stimulation of human sperm motility by relaxin. Fertil Steril 1982; 38(3):339-343.
47. Lessing JB, Brenner SH, Schoenfeld C et al. The effect of relaxin on the motility of sperm in freshly thawed human semen. Fertil Steril 1985; 44(3):406-409.
48. Lessing JB, Brenner SH, Colon JM et al. Effect of relaxin on human spermatozoa. J Reprod Med 1986; 31(5):304-309.
49. Colon JM, Ginsburg F, Lessing JB et al. The effect of relaxin and prostaglandin E2 on the motility of human spermatozoa. Fertil Steril 1986; 46(6):1133-1139.
50. Han YJ, Miah AG, Yoshida M et al. Effect of relaxin on in vitro fertilization of porcine oocytes. J Reprod Dev 2006; 52(5):657-662.
51. Park JM, Ewing K, Miller F et al. Effects of relaxin on the fertilization capacity of human spermatozoa. Am J Obstet Gynecol 1988; 158(4):974-979.
52. Brenner SH, Lessing JB, Schoenfeld C et al. Stimulation of human sperm cervical mucus penetration in vitro by relaxin. Fertil Steril 1984; 42(1):92-96.
53. Pupula M, Quinn P, MacLennan A. The effect of porcine relaxin on the fertilisation of mouse oocytes in vitro. Clin Reprod Fertil 1986; 4(6):383-387.
54. Miah AG, Tareq KM, Hamano KI et al. Effect of Relaxin on Acrosome Reaction and Utilization of Glucose in Boar Spermatozoa. J Reprod Dev 2006; 52(6):773-779.
55. Chan SYW, Tang LCH. Lack of effect of exogenous relaxin on the fertilizing capacity of human spermatozoa. IRCS Med Sci 1984; 12:879-880.
56. Conklin D, Lofton-Day CE, Haldeman BA et al. Identification of INSL5, a new member of the insulin superfamily. Genomics 1999; 60(1):50-56.
57. Lok S, Johnston DS, Conklin D et al. Identification of INSL6, a new member of the insulin family that is expressed in the testis of the human and rat. Biol Reprod 2000; 62(6):1593-1599.
58. Chassin D, Laurent A, Janneau JL et al. Cloning of a new member of the insulin gene superfamily (INSL4) expressed in human placenta. Genomics 1995; 29(2):465-470.
59. Lu C, Walker WH, Sun J et al. Insulin-Like Peptide 6: Characterization of Secretory Status and Posttranslational Modifications. Endocrinology 2006; 147(12):5611-5623.
60. Bogatcheva NV, Truong A, Feng S et al. GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol 2003; 17(12):2639-2646.
61. Liu C, Chen J, Kuei C et al. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol Pharmacol 2005; 67(1):231-240.
62. Liu C, Kuei C, Sutton S et al. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J Biol Chem 2005; 280(1):292-300.
63. Adham IM, Agoulnik AI. Insulin-like 3 signalling in testicular descent. Int J Androl 2004; 27(5):257-265.
64. Bogatcheva NV, Agoulnik AI. INSL3/LGR8 role in testicular descent and cryptorchidism. Reprod Biomed Online 2005; 10(1):49-54.
65. Hutson JM. A biphasic model for the hormonal control of testicular descent. Lancet 1985; 2(8452):419-421.
66. Barteczko KJ, Jacob MI. The testicular descent in human. Origin, development and fate of the gubernaculum Hunteri, processus vaginalis peritonei and gonadal ligaments. Adv Anat Embryol Cell Biol 2000; 156:III-X, 1-98.
67. Hutson JM, Hasthorpe S, Heyns CF. Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 1997; 18(2):259-280.
68. Hrabovszky Z, Di Pilla N, Yap T et al. Role of the gubernacular bulb in cremaster muscle development of the rat. Anat Rec 2002; 267(2):159-165.
69. Thonneau PF, Gandia P, Mieusset R. Cryptorchidism: incidence, risk factors and potential role of environment; an update. J Androl 2003; 24(2):155-162.
70. Morley R, Lucas A. Undescended testes in low birthweight infants. Br Med J (Clin Res Ed) 1987; 295(6601):753.
71. Zimmermann S, Steding G, Emmen JM et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999; 13(5):681-691.
72. Nef S, Parada LF. Cryptorchidism in mice mutant for Insl.3 Nat Genet 1999; 22(3):295-299.
73. Kubota Y, Temelcos C, Bathgate RA et al. The role of insulin 3, testosterone, Mullerian inhibiting substance and relaxin in rat gubernacular growth. Mol Hum Reprod 2002; 8(10):900-905.
74. Overbeek PA, Gorlov IP, Sutherland RW et al. A transgenic insertion causing cryptorchidism in mice. Genesis 2001; 30(1):26-35.
75. Nguyen MT, Showalter PR, Timmons CF et al. Effects of orchiopexy on congenitally cryptorchid insulin-3 knockout mice. J Urol 2002; 168(4 Pt 2):1779-1783.
76. Gorlov IP, Kamat A, Bogatcheva NV et al. Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet 2002; 11(19):2309-2318.
77. Koskimies P, Suvanto M, Nokkala E et al. Female mice carrying a ubiquitin promoter-Insl3 transgene have descended ovaries and inguinal hernias but normal fertility. Mol Cell Endocrinol 2003; 206(1-2):159-166.
78. Adham IM, Steding G, Thamm T et al. The overexpression of the insl3 in female mice causes descent of the ovaries. Mol Endocrinol 2002; 16(2):244-252.
79. Bullesbach EE, Rhodes R, Rembiesa B et al. The relaxin-like factor is a hormone. Endocrine 1999; 10(2):167-169.
80. Wensing CJ. The embryology of testicular descent. Horm Res 1988; 30(4-5):144-152.
81. Wensing CJ, Colenbrander B. Normal and abnormal testicular descent. Oxf Rev Reprod Biol 1986; 8:130-164.
82. Heyns CF, Hutson JM. Historical review of theories on testicular descent. J Urol 1995; 153(3 Pt 1):754-767.
83. Hutson JM, Beasley SW. Embryological controversies in testicular descent. Semin Urol 1988; 6(2):68-73.
84. Hsu SY, Nakabayashi K, Nishi S et al. Activation of orphan receptors by the hormone relaxin. Science 2002; 295(5555):671-674.
85. Kumagai J, Hsu SY, Matsumi H et al. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 2002; 277(35):31283-31286.
86. Sudo S, Kumagai J, Nishi S et al. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 2003; 278(10):7855-7862.
87. Feng S, Bogatcheva NV, Kamat AA et al. Genetic targeting of relaxin and insl3 signaling in mice. Ann N Y Acad Sci 2005; 1041:82-90.
88. Emmen JM, McLuskey A, Adham IM et al. Hormonal control of gubernaculum development during testis descent: gubernaculum outgrowth in vitro requires both insulin-like factor and androgen. Endocrinology 2000; 141(12):4720-4727.
89. Hsu SY, Nakabayashi K, Nishi S et al. Relaxin signaling in reproductive tissues. Mol Cell Endocrinol 2003; 202(1-2):165-170.
90. Pusch W, Balvers M, Ivell R. Molecular cloning and expression of the relaxin-like factor from the mouse testis. Endocrinology 1996; 137(7):3009-3013.
91. Zimmermann S, Schottler P, Engel W et al. Mouse Leydig insulin-like (Ley I-L) gene: structure and expression during testis and ovary development. Mol Reprod Dev 1997; 47(1):30-38.
92. Boockfor FR, Fullbright G, Bullesbach EE et al. Relaxin-like factor (RLE) serum concentrations and gubernaculum RLF receptor display in relation to pre- and neonatal development of rats. Reproduction 2001; 122(6):899-906.
93. Visel A, Thaller C, Eichele G. GenePaint.org: an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res 2004; 32(Database issue):D552-556.
94. Balvers M, Spiess AN, Domagalski R et al. Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 1998; 139(6):2960-2970.
95. Emmen JM, McLuskey A, Adham IM et al. Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 2000; 141(2):846-849.
96. Nef S, Shipman T, Parada LF. A molecular basis for estrogen-induced cryptorchidism. Dev Biol 2000; 224(2):354-361.
97. Sadeghian H, Anand-Ivell R, Balvers M et al. Constitutive regulation of the Insl3 gene in rat Leydig cells. Mol Cell Endocrinol 2005; 241(1-2):10-20.
98. Foresta C, Bettella A, Vinanzi C et al. A novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab 2004; 89(12):5952-5958.
99. Bay K, Hartung S, Ivell R et al. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab 2005; 90(6):3410-3418.
100. Hombach-Klonisch S, Schon J, Kehlen A et al. Seasonal expression of INSL3 and Lgr8/Insl3 receptor transcripts indicates variable differentiation of Leydig cells in the roe deer testis. Biol Reprod 2004; 71(4):1079-1087.
101. Truong A, Bogatcheva NV, Schelling C et al. Isolation and expression analysis of the canine insulin-like factor 3 gene. Biol Reprod 2003; 69(5):1658-1664.
102. Jeyasuria P, Ikeda Y, Jamin SP et al. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol 2004; 18(7):1610-1619.
103. Koskimies P, Levallet J, Sipila P et al. Murine relaxin-like factor promoter: functional characterization and regulation by transcription factors steroidogenic factor 1 and DAX-1. Endocrinology 2002; 143(3):909-919.
104. Robert NM, Martin LJ, Tremblay JJ. The orphan nuclear receptor NR4A1 regulates insulin-like 3 gene transcription in Leydig cells. Biol Reprod 2006; 74(2):322-330.
105. Agoulnik AI. Mouse mutants of relaxin, insulin-like 3 peptide and their receptors. Curr Med Chem Immunol Endocr Metab Agents 2005; 5(5):411-419.
106. Anand-Ivell RJ, Relan V, Balvers M et al. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol Reprod 2006; 74(5):945-953.
107. Feng S, Bogatcheva NV, Truong A et al. Over expression of insulin-like 3 does not prevent cryptorchidism in GNRHR or HOXA10 deficient mice. J Urol 2006; 176(1):399-404.
108. Kawamura K, Kumagai J, Sudo S et al. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA 2004; 101(19):7323-7328.
109. Del Borgo MP, Hughes RA, Bathgate RA et al. Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo. J Biol Chem 2006; 281(19):13068-13074.
110. Tomboc M, Lee PA, Mitwally MF et al. Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 2000; 85(11):4013-4018.
111. Ferlin A, Bogatcheva NV, Gianesello L et al. Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization. Mol Hum Reprod 2006; 12(6):401-406.
112. Canto P, Escudero I, Soderlund D et al. A novel mutation of the insulin-like 3 gene in patients with cryptorchidism. J Hum Genet 2003; 48(2):86-90.
113. Lim HN, Raipert-de Meyts E, Skakkebaek NE et al. Genetic analysis of the INSL3 gene in patients with maldescent of the testis. Eur J Endocrinol 2001; 144(2):129-137.
114. Bullesbach EE, Schwabe C. Tryptophan B27 in the relaxin-like factor (RLE) is crucial for RLF receptor-binding. Biochemistry 1999; 38(10):3073-3078.
115. Ferlin A, Simonato M, Bartoloni L et al. The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism. J Clin Endocrinol Metab 2003; 88(9):4273-4279.
116. Bogatcheva NV, Ferlin A, Feng S et al. T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane. Am J Physiol Endocrinol Metab 2007; 292(1):138-144.